Corrigendum to “PI3K/Akt/mTOR signaling orchestrates the phenotypic transition and chemo-resistance of small cell lung cancer” [J. Genet. Genom. (2021) 48, 640–651]

doi: 10.1016/j.jgg.2025.04.021

• Xuefeng Li ^a,b,c , 
• Cheng Li ^c , 
• Chenchen Guo ^a,b , 
• Qiqi Zhao ^a,b,d , 
• Jiayu Cao ^b,e , 
• Hsin-Yi Huang ^a , 
• Meiting Yue ^a,b , 
• Yun Xue ^a,b , 
• Yujuan Jin ^a     , 
• Liang Hu ^a     , 
• Hongbin Ji ^a,b,d,f    

•  

  a. State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China;

•  

  b. University of Chinese Academy of Sciences, Beijing 100049, China;

•  

  c. Department of Medical Oncology, The First Affiliated Hospita, Hengyang MedicalSchool, University of South China, Hengyang, Hunan 421001, China;

•  

  d. School of Life Science and Technology, Shanghai Tech University, Shanghai 200120, China;

•  

  e. CAS Key Laboratory of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China;

•  

  f. School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China